- Year Founded: 1995
- Headquarters: Shenzhen,China
- Estimated Employees: 1700
- Product Lines:
- Clinical Chemistry
- Lab Automation
- Immunoassay Kit and Clinical Chemistry Kit
- MAGLUMI X8/4000 Plus/2000 Plus automated CLIA analyzer
- Biossays BC2200/BC1200 Clinical Chemistry analyzer
Shenzhen New Industries Biomedical Engineering Co., Ltd. (Briefed as Snibe Co.,Ltd) is located in National Biological Industry Park(Shenzhen China), founded in December 1995 with a registered capital of CNY 370,400,000. Snibe is a bio-medical company specialized in clinical laboratory instruments and in vitro diagnostic reagents. Snibe has formed a strong team of professionals: Reagents R & D and production center, Instruments R & D and production center, Sales & Marketing center.
In July 2017, Snibe passed the FDA 510(k) review of the United States and obtained an entry permit, officially becoming the first chemiluminescent manufacturer in China to receive the FDA approval.
In 2018, Snibe successfully released the global fast and fully automated chemiluminescence immunoassay system MAGLUMI® X8. In July 2019, New Industry Biology’s independently developed hepatitis C chemiluminescence product successfully passed the EU CE certification and became the first hepatitis C in China Reagents can pass the highest CE certified chemiluminescent manufacturers in the EU.
Snibe is the first company in China to adopt the most advanced "nanoimmunomagnetic microbeads" as the key separation material of the system. The first company in China to use the most advanced "artificially synthesized small molecule organic compounds" in the field instead of traditional enzymes as luminescent markers. The first company in China to apply direct chemiluminescence immunoassay technology and realize mass production of fully automatic chemiluminescence immunoassay instruments and supporting reagents.